| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/01/2004 | US20040063147 Novel applications of acridinium compounds and derivatives in homogeneous assays |
| 04/01/2004 | CA2768674A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 04/01/2004 | CA2499964A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | CA2499701A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | CA2499326A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | CA2498946A1 2,4-substituted indoles and their use as 5-ht6 modulators |
| 04/01/2004 | CA2498781A1 Indolinones substituted by heterocycles, their preparation thereof and their use as medicaments |
| 04/01/2004 | CA2498335A1 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 04/01/2004 | CA2497971A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | CA2496765A1 2,7-substituted indoles and their use as 5-ht6 modulators |
| 04/01/2004 | CA2496624A1 1-pyridin-4-yl-urea derivatives |
| 04/01/2004 | CA2496306A1 Substituted heterocyclylpyrimidines |
| 03/31/2004 | EP1403303A1 Methods for the preparation of poly(etherimide)s |
| 03/31/2004 | EP1403269A1 Remedial agent for viral infectious disease |
| 03/31/2004 | EP1403255A1 Rho KINASE INHIBITORS |
| 03/31/2004 | EP1403254A1 Novel applications of acridinium compounds and derivatives in homogeneous assays |
| 03/31/2004 | EP1403251A1 Bis(2-aryl-5-pyridyl) derivative |
| 03/31/2004 | EP1403250A1 Bis(5-aryl-2-pyridyl) derivative |
| 03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
| 03/31/2004 | EP1401833A2 Chemical derivatives and the use thereof as an anti-elomerase agent |
| 03/31/2004 | EP1401831A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
| 03/31/2004 | EP1401830A2 Quinazolinediones as antibacterial agents |
| 03/31/2004 | EP1401829A1 Novel heterocyclic antibacterial compounds |
| 03/31/2004 | EP1401828A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 03/31/2004 | EP1401827A2 Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators |
| 03/31/2004 | EP1401826A1 Pyrazole derivatives as hiv reverse transcriptase inhibitors |
| 03/31/2004 | EP1401820A1 5-ht receptor ligands and uses thereof |
| 03/31/2004 | EP1401819A1 5-ht receptor ligands and uses thereof |
| 03/31/2004 | EP1401817A1 Isoquinoline compounds having antiinfective activity |
| 03/31/2004 | EP1401813A1 New indole derivatives with 5-ht6 receptor affinity |
| 03/31/2004 | EP1401453A2 Protease inhibitors |
| 03/31/2004 | EP1401451A2 Quinazoline derivatives which promote the release of parathyroid hormone |
| 03/31/2004 | EP1401442A1 S-omeprazole (esomeprazole inclusion complex with cyclodextrins |
| 03/31/2004 | EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 03/31/2004 | EP1401416A2 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) |
| 03/31/2004 | EP1401414A2 Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms) |
| 03/31/2004 | EP1401413A2 Use of tyrosine kinase inhibitions for treating allergic diseases |
| 03/31/2004 | EP1401412A2 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 03/31/2004 | EP1401411A2 Use of tyrosine kinase inhibitors for treating bone loss |
| 03/31/2004 | EP1370258A4 Peptide deformylase inhibitors |
| 03/31/2004 | EP1177186B1 Ureas and their use as cell adhesion modulators |
| 03/31/2004 | EP1073438B1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDINE)-5H-BENZO (5,6) CYCLOHEPTA (1,2-b) PYRIDINE ORAL COMPOSITIONS |
| 03/31/2004 | EP0788358B1 Use of pyrazole compounds for the treatment of glomerulonephritis, cancer, atherosclerosis or restenosis |
| 03/31/2004 | EP0781766B1 Heterocyclic derivative and medicine |
| 03/31/2004 | CN1486315A Dehalogeno compounds |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486309A Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 03/31/2004 | CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 03/31/2004 | CN1486301A 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 03/31/2004 | CN1143857C Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 03/31/2004 | CN1143856C Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) [1,4] diazepan-1-yl)-1-(aryl) butyl) benzamides useful for treatment of allergic diseases |
| 03/31/2004 | CN1143855C I (ortho)-anthranilamide derivatives as anti-coagulants |
| 03/31/2004 | CN1143853C Preparing method for anti-viral compounds |
| 03/31/2004 | CN1143849C Pyridine ketones used as herbicides |
| 03/31/2004 | CN1143848C 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists |
| 03/31/2004 | CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 03/30/2004 | US6713651 β2-adrenergic receptor agonists |
| 03/30/2004 | US6713650 ABCA-1 elevating compounds |
| 03/30/2004 | US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
| 03/30/2004 | US6713629 5,5-Disubstituted thiazolidine derivative pesticides |
| 03/30/2004 | US6713603 Adjusted nucleotide sequences for use as antisense tools in genetic engineering |
| 03/30/2004 | US6713502 Anti-infectives |
| 03/30/2004 | US6713496 3-(imidazolyl)-2-alkoxypropanoic acids |
| 03/30/2004 | US6713495 Magnesium omeprazole |
| 03/30/2004 | US6713491 For use as medicine for antagonising the effects of excitatory amino acids upon the nmda receptor complex |
| 03/30/2004 | US6713490 6-(2-(4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl)-1-hydroxy -ethyl)-3,4-dihydro-2(1h)-quinolinone; reduced inhibitory activity at herg (human ether-a-go-go related gene) potassium channel |
| 03/30/2004 | US6713489 Treatment of atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, pancreatitis, myocardial infarction, stroke, restenosis, or syndrome x |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713486 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof |
| 03/30/2004 | US6713482 Such as (e)-1-(2-pyridyl)-2-styryl-1h-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 03/30/2004 | US6713473 6-carbamate-1,2,3,4-tetrahydrocarbazole derivatives; affinity for neuropeptide y receptors |
| 03/30/2004 | US6713472 Thiazine or pyrazine derivatives |
| 03/30/2004 | US6713467 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and metastasis inhibitors in treating cancer |
| 03/30/2004 | CA2264513C Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 03/30/2004 | CA2217499C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 03/30/2004 | CA2194502C 2-[1',2',4'-triazol-3'-yloxymethylene]anilides, their preparation and their use |
| 03/30/2004 | CA2077742C Syringe with protective housing |
| 03/30/2004 | CA2067924C N-alkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
| 03/25/2004 | WO2004024721A1 Hydantoin derivatives und deren verwendung als tace inhibitoren |
| 03/25/2004 | WO2004024720A1 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 03/25/2004 | WO2004024719A1 Substituted 1,4-pyrazine derivatives |
| 03/25/2004 | WO2004024718A1 Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors |
| 03/25/2004 | WO2004024717A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 03/25/2004 | WO2004024716A1 Process for producing cilostazol |
| 03/25/2004 | WO2004024715A1 Sulphonamide derivatives and their use as tace inhibitors |
| 03/25/2004 | WO2004024714A1 Aroyl-piperidine derivatives |
| 03/25/2004 | WO2004024713A1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents |
| 03/25/2004 | WO2004024712A1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same |
| 03/25/2004 | WO2004024710A1 Urea compounds active as vanilloid receptor antagonists for the treatment of pain |
| 03/25/2004 | WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 03/25/2004 | WO2004024701A1 Heterocyclic derivatives |
| 03/25/2004 | WO2004024700A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 03/25/2004 | WO2004024699A1 Benzimidazolones and their use as cytokine inhibitors |
| 03/25/2004 | WO2004024698A1 1-sulphonyl piperidine derivatives |
| 03/25/2004 | WO2004024697A1 Amine compounds and use thereof |
| 03/25/2004 | WO2004024693A1 Heterocyclic compound having hiv integrase inhibitory activity |
| 03/25/2004 | WO2004024682A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity. |
| 03/25/2004 | WO2004024162A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds |